The Department of Veterans Affairs is currently examining the therapeutic use of psychedelics, including MDMA, also known as ecstasy, the active ingredient in psychedelic mushrooms, to combat post-traumatic stress disorder (PTSD) and depression among veterans, as reported by Joe Davidson. This move reflects a growing mainstream acceptance of psychedelics for mental health treatment. Additionally, a bill allowing the therapeutic use of Psilocybin, commonly known as magic mushrooms, has received bipartisan support in Arizona, indicating a wider acceptance and potential shift in policy towards psychedelic drugs in the United States. Discussions also extend to the potential benefits for Ukrainian soldiers coping with the horrors of war, highlighted by AlexanderBeiner.
A bill to permit therapeutic use for Psilocybin (magic mushrooms) has recieved bipartisan support in Arizona. https://t.co/BBpRXAN0Fm
‘Can ketamine and MDMA help Ukrainian soldiers cope with the horrors of war?’ @AlexanderBeiner: 👇https://t.co/ET8byXU4Yd
Psychedelics are becoming so mainstream that the Department of Veterans Affairs is examining the use of MDMA — also known as ecstasy, the active ingredient in psychedelic mushrooms, to fight post-traumatic stress disorder (PTSD) and depression. https://t.co/i6SUt73Nqj
Working on my proposition that psychedelics loosen the body/brain's hold on the soul.
Many veterans who have seen the recents are heralding this: VA considers using psychedelic drugs to fight PTSD https://t.co/68StjAoRyq @JoeDavidsonWP
Perspective by Joe Davidson: Psychedelics are becoming so mainstream that the Department of Veterans Affairs is examining the use of MDMA, the active ingredient in psychedelic mushrooms, to fight post-traumatic stress disorder (PTSD) and depression. https://t.co/XAGwehEvoP